Biolife Solutions (BLFS) Gross Margin (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Gross Margin of 63.62% for Q1 2026, down 349.0% year-over-year from 25.55% in Q1 2025, and up 195.76% quarter-over-quarter from 66.44% in Q4 2025.
Biolife Solutions (BLFS) Gross Margin (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Gross Margin for 17 consecutive years, with 63.62% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 349.0% year-over-year to 63.62%; the TTM figure through Mar 2026 stood at 58.62% (up 333.0% YoY), while the FY2025 annual figure was 64.56%, down 255.0% from the prior year.
- Gross Margin advanced to 63.62% in Q1 2026 per BLFS's latest filing, from 66.44% in the prior quarter.
- Across five years, Gross Margin topped out at 207.86% in Q4 2023 and bottomed at 66.44% in Q4 2025.
- Historically, Gross Margin has averaged 79.54% across 5 years, with a median of 94.71% in 2022.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 11865 bps — and 2024, when it plunged 25208 bps.
- Biolife Solutions' Gross Margin stood at 89.21% in 2022, then jumped by 133 bps to 207.86% in 2023, then sank by 121 bps to 44.22% in 2024, then slumped by 50 bps to 66.44% in 2025, then surged by 196 bps to 63.62% in 2026.
- Business Quant data shows BLFS's Gross Margin at 63.62% in Q1 2026, 66.44% in Q4 2025, and 99.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.20 Bn | 128.98 Bn | 1.96 Bn | 67.78% |
| 2 | Becton Dickinson | 52.40 Bn | 51.54 Bn | 2.32 Bn | 46.46% |
| 3 | Alcon | 35.70 Bn | 34.35 Bn | 1.68 Bn | 59.33% |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 58.84% |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | 28.82% |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn | 37.74% |
| 7 | Solventum | 15.36 Bn | 14.96 Bn | 1.29 Bn | 58.22% |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 68.00% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 34.86% |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 64.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.24% |
| Mar 31, 2026 | 63.62% |
| Dec 31, 2025 | -66.44% |
| Sep 30, 2025 | 99.98% |
| Jun 30, 2025 | 99.96% |
| Mar 31, 2025 | 67.11% |
| Dec 31, 2024 | -44.22% |
| Sep 30, 2024 | 99.96% |
| Jun 30, 2024 | 69.87% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 207.86% |
| Sep 30, 2023 | 95.47% |
| Jun 30, 2023 | 94.20% |
| Mar 31, 2023 | 89.68% |
| Dec 31, 2022 | 89.21% |
| Sep 30, 2022 | 95.39% |
| Jun 30, 2022 | 95.89% |
| Mar 31, 2022 | 94.71% |
| Dec 31, 2021 | 29.24% |
| Sep 30, 2021 | 35.88% |